Coventry Health Care gets good bill of health

Coventry Health Care's (NYSE: CVH) earnings report from late April won't make anybody ill. Operaring revenues were up 15.4% to $2.24 billion. Net earnings were $127.5 million and diluted EPS were $.80, excluding a $.04 per share debt refinancing charge. Coventry is growing both organically and by acquisition. It purchased Concentra worker's compensation business unit in order to gain a national market, and has announced plans to acquire selected assets of Mutual of Omaha's health insurance business in the near future. In order to finance these acquisitions, Coventry Health Care retired $170.5 million in debt at 8.125 % to refinance $400 million of debt at 5.95%. The company also bought back 4 million of its own shares for $221 million.

According to CEO Dale Wolf, the company is doing exactly what it promised shareholders it would do: acquire strategic assets, buy back its own stock, refinance debt to more favorable terms, and launch new products and/or policies. One policy that Coventry has been pursuing is to raise premium yields on its members. Current Coventry members yield $271.03 in premiums per month, an increase of 5.6%. But expenses increased 4.8% to $212.43 during that same period, thereby negating most of the increase in premiums.

Coventry forecasts 2Q 2007 revenues of $2.3-$2.4 billion, yielding diluted EPS of $.94-$.96. FY 2007 total revenues are forecast at $8.1-$8.4 billion, yielding diluted EPS of $3.92-$3.98 icluding $.04 per share debt refinancing charges. The stiock opened the year at $49.81, and closed recently at $59.63, a respectable 20% run-up in share price. But health care costs have become a hot topic in Democratic presidential debates recently, and insurance companies have been held responsible for runaway costs and substandard treatment complaints. At half the size of health insurance giant Aetna (NYSE: AET), Coventry is a slightly better deal in terms of its p/e multiple, but there are more attractive investments out there than either one of these.